ADXS — Ayala Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $1.28m
- $4.21m
- $0.01m
Annual cashflow statement for Ayala Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16.6 | -26.5 | -17.9 | -14.4 | -48.1 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 3.41 | 5.14 | 1.34 | -1.52 | 17.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -24.4 | -1.85 | 0.42 | 0.313 | 1.1 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -36.1 | -21.9 | -15.4 | -15.3 | -29.5 |
| Capital Expenditures | -1.28 | -0.748 | -0.46 | -0.201 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.083 | — | 0.449 | 0.035 | 5.95 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.2 | -0.748 | -0.011 | -0.166 | 5.95 |
| Financing Cash Flow Items | -0.001 | 0 | 0 | -0.018 | 20 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 24.6 | 15.5 | 31.9 | -0.956 | 26 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -12.8 | -7.18 | 16.4 | -16.4 | 2.49 |